Uppsala Reports editor
@UMCGlobalSafety
Illustration: UMC
UMC promotes pharmacovigilance by developing posters for display at scientific events around the world. The three new posters shown here were presented at the ISPE 35th ICPE Pharmacoepidemiology & Therapeutic Risk Management Conference August 2019, in Philadelphia, USA.
Read more:
UMC's scientific poster library
Uppsala Reports editor
@UMCGlobalSafety
An Australian research team is using artificial intelligence to improve the safe dosing of unfractionated heparin, a high-risk drug linked to serious side effects.
30 March 2026
Analysis of paired reports from the Norwegian ADR Registry suggests merging consumer and healthcare professional accounts of the same adverse event may improve causality assessment
19 August 2026
Complementary medicines are widely used and often perceived as safe, yet high doses, product stacking, and unclear labelling can quietly increase the risk of harm.
07 April 2026